AYUMU GOTO: 'Daicho Gan Kagaku Ryoho -Saikin no Heiyo Toyo- TS-1/Irinotecan Heiyo Ryoho -Genzai no Chiken' JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY vol. 33, no. 7, 2006, pages 896 - 900, XP008180949 (B1)

SOTARO SADAHIRO ET AL.: 'Two Patients with Recurrent Colon Cancer Who Underwent Surgery Following a Combination of Irinotecan and UFT' JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY vol. 29, no. 11, 2002, pages 2013 - 2018, XP008180952 (B1)

TEMMINK, O.H. ET AL.: 'Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.' EUROPEAN JOURNAL OF CANCER vol. 43, no. 1, 2007, pages 175 - 183, XP005834920 (B1)

YOSHINO ET AL: "TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial", LANCET/ONCOLOGY, vol. 13, no. 10, October 2012 (2012-10), pages 993-1001, XP002762779, ISSN: 1470-2045, DOI: 10.1016/S1470-2045(12)70345-5 (B1)

WO-A1-2006/080327 (B1)

YAMAZAKI, K. ET AL.: 'A first combination phase I study of TAS-102 and irinotecan (Iri) in Japanese patients (pts) with metastatic colorectal cancer (mCRC) refractory to fluoropyrimidine (FU) and oxaliplatin (Ox).' EUROPEAN JOURNAL OF CANCER vol. 49, no. SUPPL., September 2013, page S555, XP055291370 (B1)

TEMMINK, O.H. ET AL.: 'Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.' CANCER SCI. vol. 98, no. 6, 2007, pages 779 - 789, XP055281121 (B1)